Hosted on MSN24y
AstraZeneca Expands Savings Program for Respiratory Medicines, Aiming to Ease Patient Costs
In a significant move aimed at enhancing access to essential respiratory care, AstraZeneca recently announced plans to broaden its savings programs across its entire US inhaled respiratory ...
pharmaphorum2d
Update: FDA clears first generic of AZ's blockbuster Symbicort
Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...